Verition Fund Management
VBIV

Verition Fund Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Verition Fund Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-538
Closed -$11K – 2946
2022
Q3 		$11K Hold
538
– – ﹤0.01% 2859
2022
Q2 		$13K Buy
+538
New +$18.3K ﹤0.01% 2244
2021
Q2 		– Sell
-5,797
Closed -$541K – 2243
2021
Q1 		$541K Buy
+5,797
New +$588K 0.01% 830

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return